
Journal of Chemical Crystallography p. 952 - 959 (2012)
Update date:2022-08-03
Topics:
Shuler, William G.
Smith, Ellyn A.
Hess, Sloan M.
McFadden, Thomas M. C.
Metz, Clyde R.
Vanderveer, Donald G.
Pennington, William T.
Mabe, Phillip J.
Knick, Shabree L.
Beam, Charles F.
2-Methylbenzoic acid phenylhydrazide was polylithiated with excess lithium diisopropylamide, and the resulting polylithiated intermediate was condensed with methyl 4-dimethylaminobenzoate or methyl 4-methoxybenzoate to afford C-acylated intermediates that were immediately acid cyclized to afford 3-(4-(dimethylamino)-phenyl)-2-(phenylamino)isoquinolin-1(2H)-one C 23H21N3O or 3-(4-methoxyphenyl)-2-(phenylamino) isoquinolin-1(2H)-one C22H18N2O2. The polylithiated intermediate underwent N-acylation when it was condensed with methyl 4-methylbenzoate to give 2-methyl-N′-(4-methylbenzoyl)-N′- phenylbenzohydrazide C22H20N2O2. Crystals of C23H21N3O 4a are triclinic, P $ overline{1} $, a = 9.138(2) A, b = 10.519(2) A, c = 11.082(2) A, α = 91.55(3)°, β = 108.92(3)°, γ = 111.16(3)°, Z = 2, V = 927.1(3) A3, R 1 = 0.0711 and wR 2 = 0.1828 for reflections with I > 2σ(I); crystals of C22H18N2O2 4b are monoclinic, P21/c, a = 8.821(1) A, b = 13.276(2) A, c = 15.482(3) A, β = 105.271(4)°, Z = 4, V = 1748.9(5) A3, R 1 = 0.0416 and wR 2 = 0.1030 for reflections with I > 2σ(I); crystals of C22H20N2O2 3 are orthorhombic, Pbca, a = 13.505(3) A, b = 9.733(2) A, c = 28.601(6) A, Z = 8, V = 3759.4(13) A3, R 1 = 0.1683 and wR 2 = 0.3526 for reflections with I > 2σ(I). Index Abstract: X-ray crystal analysis was important for the confirmation of the structure of 3-(4-(dimethylamino)phenyl)-2-(phenylamino)isoquinolin-1(2H)-one C23H21N3O 4a, 3-(4-methoxyphenyl)-2- (phenylamino)isoquinolin-1(2H)-one C22H18N 2O2 4b, and 2-methyl-N′-(4-methylbenzoyl)-N′- phenylbenzohydrazide C22H20N2O2 3 prepared from polylithiated 2-methylbenzoicacid phenylhydrazide and methyl 4-dimethylaminobenzoate, methyl 4-methoxybenzoate, or methyl 4-methylbenzoate. Crystals of C23H21N3O 4a are triclinic, P, a = 9.138(2) A, b = 10.519(2) A, c = 11.082(2) A, α = 91.55(3)°, β = 108.92(3)°, γ = 111.16(3)°, Z = 2, V = 927.1(3) A3, R 1 = 0.0711 and wR 2 = 0.1828 for reflections with I > 2σ(I); crystals of C22H 18N2O2 4b are monoclinic, P21/c, a = 8.821(1) A, b = 13.276(2) A, c = 15.482(3) A, β = 105.271(4)°, Z = 4, V = 1748.9(5) A3, R 1 = 0.0416 and wR 2 = 0.1030 for reflections with I > 2σ(I); crystals of C22H20N2O2 3 are orthorhombic, Pbca, a = 13.505(3) A, b = 9.733(2) A, c = 28.601(6) A, Z = 8, V = 3759.4(13) A3, R 1 = 0.1683 and wR 2 = 0.3526 for reflections with I > 2σ(I).
SHIJIAZHUANG AGERUO-BIOTECH CO.LTD
Contact:+86-130-2866-6699
Address:Huaian east Road 158
Contact:+86+21-58956006 15800617331
Address:402 Room, 150# Cailun Road, Zhangjiang high tech park, Shanghai
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Shandong Hongxiang Zinc Co., Ltd
Contact:086-0311-66187879
Address:DaWang developing zone
Hebei DaPeng Pharm & Chem Co., Ltd.
Contact:86-317-7298678,0576-88861898 88861908
Address:West Songmen Village, East Songmen Town, Wuqiao, Cangzhou, Hebei ,China
Doi:10.1007/s00044-012-0425-z
(2013)Doi:10.1016/j.tet.2012.12.014
(2013)Doi:10.1016/j.bmcl.2014.11.006
(2014)Doi:10.1016/S0040-4020(01)92261-6
(1992)Doi:10.1021/jo402085v
(2013)Doi:10.1039/c39920000648
(1992)